+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Haemochromatosis - Pipeline Insight, 2025 - Product Thumbnail Image

Haemochromatosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leptomeningeal Disease -Pipeline Insight, 2025 - Product Thumbnail Image

Leptomeningeal Disease -Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Familial Chylomicronemia Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Familial Chylomicronemia Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lamellar Icthyosis- Pipeline Insight, 2025 - Product Thumbnail Image

Lamellar Icthyosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Complement C1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C1 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cannabinoid Receptor CB1 Inverse Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Receptor CB1 Inverse Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Autistic Disorder- Pipeline Insight, 2025 - Product Thumbnail Image

Autistic Disorder- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Spasmodic-torticollis - Pipeline Insight, 2025 - Product Thumbnail Image

Spasmodic-torticollis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Histamine H1 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Histamine H1 Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
T Type Calcium Channel Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

T Type Calcium Channel Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
West Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

West Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Ragweed Pollen Hypersensitivity - Pipeline Insight, 2025 - Product Thumbnail Image

Ragweed Pollen Hypersensitivity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Advanced Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Renal Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Androgen Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Androgen Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Schnitzler Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Schnitzler Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gaucher's Disease Type I - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher's Disease Type I - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gaucher's Disease Type III - Pipeline Insight, 2025 - Product Thumbnail Image

Gaucher's Disease Type III - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lewy Body Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Lewy Body Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
TRPV1 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

TRPV1 Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more